Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Japan | 2022

The Japanese heart valve device market has been negatively impacted by the global COVID-19 pandemic; however, in the longer term, the market will be driven by an aging population in this country, improving access to treatment, positive results from THV device clinical trials, new product launches, and the rapid adoption of THV devices, resulting in strong growth through 2030.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Japan across an 11-year period.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…